Antisense down regulation of connexin31.1 reduces apoptosis and increases thickness of human and animal corneal epithelia

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 376-385

  Chang, C Y ^a   Laux Fenton, W T ^a   Law, L Y ^a   Becker, D L ^b   Sherwin, T ^a   Green, C R ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antisense oligodeoxynucleotides; Apoptosis; Connexin; Cornea; Cx31.1; Epithelium; Gap junction

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CONNEXIN31.1; DEOXYRIBOZYME; GAP JUNCTION PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TERTIARY STRUCTURE; RAT; SQUAMOUS CELL;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CONNEXINS; DNA, CATALYTIC; DOWN-REGULATION; EPITHELIUM, CORNEAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; OLIGONUCLEOTIDES, ANTISENSE; RATS; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 61349086011     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.12.006     Document Type: Article

References (41)

1. Aboul-Fadl T. Antisense oligonucleotides: the state of the art. Curr Med Chem 12 (2005) 2193-2214
2. Agrawal S., Temsamani J., Galbraith W., and Tang J. Pharmacokinetic of antisense oligonucleotides. Clin Pharm 28 (1995) 7-16
3. Becker D.L., Lin J.S., and Green C.R. Antisense technology in the central nervous system. In: Lesile R.A. (Ed). Pluronic gel as a means of antisense delivery (1999), Oxford University Press, New York
4. Budunova I.V., Carbajal S., and Slaga T.J. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 16 (1995) 2717-2724
5. Cairns M.J., Hopkins T.M., Witherington C., Wang L., and Sun L.Q. Target site selection for an RNA-cleaving catalytic DNA. Nat Biotech 17 (1999) 480-486
6. Chan J.H., Lim S., and Wong W.S. Antisense oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol 33 (2006) 533-540
7. Coutinho P., Qiu C., Frank S., Tamber K., and Becker D.L. Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 27 (2003) 525-541
8. Crooke S.T., and Bennett C.F. Progress in antisense oligonucleotide therapeutics. Ann Rev Pharmacol Toxicol 36 (1996) 107-129
9. Gatzioufas Z., Charalambous P., and Thanos S. Reduced expression of the gap junction protein connexin 43 in keratoconus. Eye 14 (2007) 14
10. Gilbert G.F. Early vertebrate development: neurolation and ectoderm. Developmental biology. 2nd ed. (1988), Sinauer Associates, Sanderland, MA 152-195
11. Gilbert G.F. Proximate tissue interactions: secondary induction. Developmental biology. 2nd ed. (1988), Sinauer Associates, Sanderland, MA
12. Gilula N.B., Kumar N.M., Warner A., Green C.R., Willecke K., Unger V.M., et al. Gap junction-mediated intercellular signalling in health and disease (1999), John Wiley & Sons Ltd., New York
13. Goliger J.A., and Paul D.L. Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis. Dev Dyn 200 (1994) 1-13
14. Goliger J.A., and Paul D.L. Wounding alters epidermal connexin expression and gap junctional-mediated intercellular communication. Mol Biol Cell 6 (1995) 1491-1501
15. Goodenough D.A., Goliger J.A., and Paul D.L. Connexins, connexons, and intercellular communication. Ann Rev Pharmacol Toxicol 65 (1996) 475-502
16. Green C.R., Law L.Y., Lin J.S., and Becker D.L. Spatiotemporal depletion of connexins using antisense oligonucleotides. In: Bruzzone R., and Giaume C. (Eds). Methods in molecular biology (2001), Humana Press, Totawa, NJ 175-185
17. Harris A.L. Emerging issues of connexin channels: biographics fills the gap. Q Rev Biophys 34 (2001) 325-472
18. Hennemann H., Dahl E., White J.B., Schwarz H.J., Lalley P.A., Chang S., et al. Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. J Biol Chem 267 (1992) 17225-17233
19. Kelsell D.P., Dumlop J., and Hodgins M.B. Human diseases: clues to cracking the connexin code?. TRENDS Cell Biol 11 (2001) 2-6
20. Krysko D.V., Mussche S., Leybaert L., and D'Herde K. Gap junctional communication and connexin43 expression in relation to apoptotic cell death and survival of granulosa cells. J Histochem Cytochem 52 (2004) 1199-1207
21. Kumar N.M., and Gilula N.B. The gap junction communication channel. Cell 84 (1996) 381-388
22. Laux-Fenton W. The role of connexins in corneal homeostasis and repair: mastering the connections to improve repair (2003), The University of Auckland, Auckland
23. Laux-Fenton W.T., Donaldson P.J., Kistler J., and Green C.R. Connexin expression patterns in the rat cornea: molecular evidence for communication compartments. Cornea 22 (2003) 457-464
24. Law L.Y., Zhang W.V., Stott N.S., Becker D.L., and Green C.R. In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family. J Biomol Tech 17 (2006) 270-282
25. Lebedeva I., and Stein C.A. Antisense oligonucleotides: promise and reality. Ann Rev Pharmacol Toxicol 41 (2001) 403-419
26. Lee N.P., Leung K.W., Wo J.Y., Tam P.C., Yeung W.S., and Luk J.M. Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. Apoptosis 11 (2006) 1215-1229
27. Macari F., Landau M., Cousin P., Mevorah B., Brenner S., Panizzon R., et al. Mutation in the gene for connexin 30.3 in a family with EKV. Am J Hum Genet 67 (2000) 1296-1301
28. Myers K.J., and Dean N.M. Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol Sci 21 (2000) 19-23
29. Ngezahayo A., Altmann B., Steffens M., and Kolb H.A. Gap junction coupling and apoptosis in GFSHR-17 granulosa cells. J Membr Biol 204 (2005) 137-144
30. Phillips M.I., and Zhang Y.C. Basic principles of using antisense oligonucleotides in vivo. Methods Enzymol 313 (2000) 46-56
31. Qiu C., Coutinho P., Frank S., Law L.Y., Martin P., Green CR., et al. Targeting connexin 43 expression accelerates the rate of wound repair. Curr Biol 13 (2003) 1697-1703
32. Santoro S., and Joyce G. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci 94 (1997) 4262-4266
33. Shurman D.L., Glazewski L., Gumpert A., Zieske J.D., and Richard G. In vivo and in vitro expression of connexins in the human corneal epithelium. Invest Ophthalmol Vis Sci. 46 (2005) 1957-1965
34. Simon A.M., and Goodenough D.A. Diverse functions of vertebrate gap junctions. TRENDS Cell Biol 8 (1998) 477-483
35. Spiller D., Giles R., Broighton C., Grzybowski J., Ruddell C., Tidd D., et al. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses. Antisense Nucleic Acid Drug 8 (1998) 281-293
36. Theiss C., Mazur A., Meller K., and Mannherz H.G. Changes in gap junction organization and decreased coupling during induced apoptosis in lens epithelial and NIH-3T3 cells. Exp Cell Res. 313 (2007) 38-52
37. Wagner R.W. Gene inhibition using antisense oligonucleotides. Nature 372 (1994) 333-335
38. Williams K., and Watsky M. Dye spread through gap junctions in the corneal epithelium of the rabbit. Curr Eye Res 16 (1997) 445-452
39. Williams K., and Watsky M. Gap junction communication in the human corneal endothelium and epithelium. Curr Eye Res 25 (2002) 29-36
40. Wright C.S., Becker D.L., Lin J.S., Warner A., and Hardy K. Stage-specific and differential expression of gap junctions in the mouse ovary: connexin-specific roles in follicular regulation. Reproduction 121 (2001) 77-88
41. Zheng-Fischhofer Q., Kibschull M., Schnichels M., Kretz M., Petrasch-Parwez E., Strotmann J., et al. Characterization of connexin31.1-deficient mice reveals impaired placental development. Dev Biol 312 (2007) 258-271